Cigarette smoking, carrier state of a or G allele of 46A>G and 79C>G polymorphisms of beta2-adrenergic receptor gene, and the risk of coronary artery disease

Kardiologia Polska

Volumn 66, Issue 4, 2008, Pages 380-386

  Zak, Iwona ^a   Sarecka Hujar, Beata ^a   Krauze, Jolanta ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Beta2 adrenergic receptor; Cigarette smoking; Coronary artery disease; Polymorphism

Indexed keywords

ADULT; ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD DONOR; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HUMAN; HYPERCHOLESTEROLEMIA; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; RISK FACTOR; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; HYPERTENSION; MIDDLE AGED; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING;

BETA 2 ADRENERGIC RECEPTOR;

ADULT; ALLELES; CASE-CONTROL STUDIES; CORONARY STENOSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MIDDLE AGED; OBESITY; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, ADRENERGIC, BETA-2; RISK FACTORS; SMOKING;

EID: 50049110396     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Johnson M. The beta-adrenoceptor. Am J Respir Crit Care Med 1998; 158: S146-53.
2. Kobilka BK, Dixon RA, Frielle T, et al. cDNA for the human beta 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor. Proc Natl Acad Sci U S A 1987; 84: 46-50.
3. Reihsaus E, Innis M, MacIntyre N, et al. Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 1993; 8: 334-9.
4. Alpert JS, Thygesen K, Antman E, et al. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000; 21: 1502-13.
5. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
6. Martinez FD, Graves PE, Baldini M, et al. Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest 1997; 100: 3184-8.
7. Khoury MJ, Flanders WD. Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls! Am J Epidemiol 1996; 144: 207-13.
8. Bristow MR. Beta-adrenergic receptor blockade in chronic heart failure. Circulation 2000; 101: 558-69.
9. Abu-Amero KK, Al-Boudari OM, Mohamed GH, et al. The Glu27 genotypes of the beta2-adrenergic receptor are predictors for severe coronary artery disease. BMC Med Genet 2006; 7: 31-5.
10. Barbato E, Berger A, Delrue L, et al. GLU-27 variant of beta2-adrenergic receptor polymorphisms is an independent risk factor for coronary atherosclerotic disease. Atherosclerosis 2007; 194: e80-6.
11. Heckbert SR, Hindorff LA, Edwards KL, et al. Beta2-adrenergic receptor polymorphisms and risk of incident cardiovascular events in the elderly. Circulation 2003; 107: 2021-4.
12. Timmermann B, Mo R, Luft FC, et al. Beta-2 adrenoceptor genetic variation is associated with genetic predisposition to essential hypertension: The Bergen Blood Pressure Study. Kidney Int 1998; 53: 1455-60.
13. Bray MS, Krushkal J, Li L, et al. Positional genomic analysis identifies the beta(2)-adrenergic receptor gene as a susceptibility locus for human hypertension. Circulation 2000; 101: 2877-82.
14. Covolo L, Gelatti U, Metra M, et al. Role of beta1- and beta2-adrenoceptor polymorphisms in heart failure: a case-control study. Eur Heart J 2004; 25: 1534-41.
15. Herrmann SM, Nicaud V, Tiret L, et al. Polymorphisms of the beta2-adrenoceptor (ADRB2) gene and essential hypertension: the ECTIM and PEGASE studies. J Hypertens 2002; 20: 229-35.
16. Castellano M, Rossi F, Giacchč M, et al. Beta(2)-adrenergic receptor gene polymorphism, age, and cardiovascular phenotypes. Hypertension 2003; 41: 361-7.
17. Drysdale CM, McGraw DW, Stack CB, et al. Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci U S A 2000; 97: 10483-8.
18. Wang Z, Chen C, Niu T, et al. Association of asthma with beta(2)-adrenergic receptor gene polymorphism and cigarette smoking. Am J Respir Crit Care Med 2001; 163: 1404-9.
19. Laustiola KE, Lassila R, Kaprio J, et al. Decreased beta-adrenergic receptor density and catecholamine response in male cigarette smokers. A study of monozygotic twin pairs discordant for smoking. Circulation 1988; 78: 1234-40.
20. Balcerzyk A, Zak I, Krauze J. Synergistic effects of apolipoprotein E gene epsilon polymorphism and some conventional risk factors on premature ischaemic heart disease development. Kardiol Pol 2007; 65: 1058-65.
21. Niemiec P, Zak I, Wita K. The 242T variant of the CYBA gene polymorphism increases the risk of coronary artery disease associated with cigarette smoking and hypercholesterolemia. Coron Artery Dis 2007; 18: 339-46.
22. Petrone A, Zavarella S, Iacobellis G, et al. Association of beta2 adrenergic receptor polymorphisms and related haplotypes with triglyceride and LDL-cholesterol levels. Eur J Hum Genet 2006; 14: 94-100.
23. Ishiyama-Shigemoto S, Yamada K, Yuan X, et al. Association of polymorphisms in the beta2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus. Diabetologia 1999; 42: 98-101.
24. Hellström L, Large V, Reynisdottir S, et al. The different effects of a Gln27Glu beta 2-adrenoceptor gene polymorphism on obesity in males and in females. J Intern Med 1999; 245: 253-9.
25. Ukkola O, Rankinen T, Weisnagel SJ, et al. Interactions among the alpha2-, beta2-, and beta3-adrenergic receptor genes and obesity-related phenotypes in the Quebec Family Study. Metabolism 2000; 49: 1063-70.